Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter double-blind randomized placebo-controlled study of Botox in neurogenic detrusor overactivity
2006-002143-83Phase 3Completed
- Sponsor
- Allergan
- Start
- Jun 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of botulinum toxin type A in detrusor hyperreflexia (DH) (3 arms), sponsored by Allergan. Primary endpoint: Number of episodes of urinary incontinence. Started Jun 2006; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
detrusor hyperreflexia (DH)
Beyond the preview
Go deeper on 2006-002143-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002143-83.